AI Insights · Timothy · July 2022
Top 5 Medical Apps on iOS in Central America, Q2 2022
In Q2 2022, the top 5 medical apps on iOS in Central America showed varied performance in downloads, revenue, and active users. Here’s a detailed look at their trends.
In Q2 2022, the performance of the top 5 medical apps on iOS in Central America demonstrated diverse trends in downloads, revenue, and active users. Below is a detailed analysis of each app's performance, based on data from Sensor Tower.
Sanford Guide from Antimicrobial Therapy, Inc. experienced stable weekly revenue, with a notable peak of approximately $2.3K in the last week of June. The app’s weekly downloads were consistent, averaging around 110 to 130, with a slight increase to 144 in mid-April. Weekly active users also showed a steady rise from 658 at the end of March to 744 by the end of June.
IMAIOS e-Anatomy by IMAIOS saw fluctuations in weekly revenue, peaking at around $1.4K in early May and $1.2K in the last week of June. Download trends were relatively stable, with a significant increase to 98 in the third week of June. Active users showed a gradual increase from 336 at the end of March to 379 by the end of June.
NYSORA Nerve Blocks from NYSORA Inc. had a varied revenue trend, peaking at about $632 in early April and reaching $581 by the end of June. Weekly downloads were low initially but saw a substantial increase to 193 in mid-May and stayed above 120 towards the end of the quarter.
amma: Pregnancy & Baby Tracker from PERIOD TRACKER & PREGNANCY AND BABY CALENDAR LIMITED showed a steady weekly revenue trend, peaking at around $672 in early April. The app’s downloads varied significantly, with a peak of 2.7K at the end of May. Active users grew steadily throughout the quarter, reaching nearly 59K by the end of June.
Butterfly iQ — Ultrasound from Butterfly Network had inconsistent weekly revenue, peaking at around $1.4K in mid-May. Downloads fluctuated, with a notable increase to 82 in late May.
For more detailed insights and data, visit Sensor Tower.